AptarGroup, Inc., a global leader in drug delivery and consumer product dosing technologies, has highlighted its expanding portfolio of eye care solutions, including its newest innovation, Beat the Blink. This delivery system is designed to improve dosing accuracy and enhance the patient experience by overcoming the natural blink reflex, and it is currently part of an exclusive collaboration with Bausch and Lomb.
Health Technology Insights: AHN Offers Innovative Low-Dose Radiation Therapy for Osteoarthritis
Gael Touya, President of Aptar Pharma, emphasized that the company’s strong research and development capabilities, combined with customizable delivery systems, allow Aptar to offer a wide range of innovative eye care solutions aimed at improving dosing precision and overall user experience.
Preservative-free multidose systems are increasingly important in eye care as they can make treatments more tolerable for patients. Aptar’s portfolio is built to maintain microbiological integrity while delivering precise dosing for both prescription and over-the-counter ophthalmic applications. With more than 500 market references, the company’s solutions have become a trusted platform for safe and effective eye care delivery.
Health Technology Insights: Cone Health Announces New CEO
Beat the Blink is designed to enhance patient compliance by enabling horizontal drop delivery and protecting the formula through a tip seal suitable for preservative-free formulations. The system reduces errors caused by head tilting and ensures consistent administration. The design also meets regulatory and quality requirements, including child-resistance, bottle and ventilation improvements, microbial safety, and compatibility with a wide range of ophthalmic solutions. Commercial availability is expected within two to three years following development and industrialization.
Aptar’s Ophthalmic Squeeze Dispenser (OSD) is a leading preservative-free multidose dropper that uses mechanical Tip-Seal technology without preservatives or additives. The system has undergone microbial challenge testing and comes with methods and data to help pharmaceutical partners prepare their product dossiers.
The Advanced Preservative-Free (APF) system and APF PLUS expand the company’s preservative-free offerings to nasal, dermal, oral, and eye care applications. These systems provide mechanical microbiological protection while maintaining product stability and include the APF Futurity recyclable design, which is the first all-plastic, metal-free multidose nasal spray recognized as highly recyclable.
Aptar also offers a wide range of digital healthcare solutions to support disease prevention, diagnosis, treatment, and patient monitoring. All digital solutions are designed to be patient-friendly, intuitive, and available either as fully integrated systems or add-on technologies.
Gael Touya stated, “Our extensive R&D expertise and new delivery systems allow us to provide a leading range of eye care solutions that improve dosing precision and patient experience. Our partnership-driven approach and comprehensive services help customers address evolving needs in both prescription and over-the-counter treatments.”
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 24 December 2025
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
